BIOMAT Database Logo BIOMAT Database Logo

Nifurtimox: causal treatment of Chagas' disease. 1972

R Gönnert

UI MeSH Term Description Entries
D009581 Nitrofurans Compounds containing FURANS attached to a nitro group.
D003499 Cyclic S-Oxides Heterocyclic S-Oxides,Cyclic S Oxides,Heterocyclic S Oxides,Oxides, Cyclic S,S Oxides, Cyclic,S-Oxides, Cyclic,S-Oxides, Heterocyclic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013843 Thiazines
D014355 Chagas Disease Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON. Trypanosomiasis, South American,American Trypanosomiasis,Chagas' Disease,Trypanosoma cruzi Infection,Infection, Trypanosoma cruzi,Infections, Trypanosoma cruzi,South American Trypanosomiasis,Trypanosoma cruzi Infections,Trypanosomiasis, American

Related Publications

R Gönnert
Update on nifurtimox for treatment of Chagas disease.
April 2021, Drugs of today (Barcelona, Spain : 1998),
R Gönnert
[Nifurtimox, a bright future for treatment of Chagas disease].
April 2011, Medecine tropicale : revue du Corps de sante colonial,
R Gönnert
[Efficacy of nifurtimox for the treatment of chronic Chagas disease].
February 2012, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia,
R Gönnert
[Treatment of Chagas' disease with nifurtimox during the first months of life].
January 1985, Medicina,
R Gönnert
[Treatment of chronic Chagas' disease with an association of nifurtimox and corticoid].
January 2002, Revista da Sociedade Brasileira de Medicina Tropical,
R Gönnert
Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment.
June 2014, BMC infectious diseases,
R Gönnert
Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease.
August 2022, Pharmaceutics,
R Gönnert
Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States.
October 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
R Gönnert
Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease.
August 2019, PLoS neglected tropical diseases,
R Gönnert
Adverse Events Associated with Nifurtimox Treatment for Chagas Disease in Children and Adults.
January 2021, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!